Matches in Nanopublications for { ?s ?p "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion description "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.
- NP615190.RAUA5xRVmNUdVXn-b9uwMbej-fUHIgW7aZd9L0Jj_exb8130_assertion description "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615190.RAUA5xRVmNUdVXn-b9uwMbej-fUHIgW7aZd9L0Jj_exb8130_provenance.
- NP705151.RAbdQRr4eGYL1uvL1zS5XCbUfePsWwjBXJvi9WeanJVfA130_assertion description "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705151.RAbdQRr4eGYL1uvL1zS5XCbUfePsWwjBXJvi9WeanJVfA130_provenance.
- NP545608.RArYhzCQPUQgs3s_ZL8mBXU6rsHisUiF6-J3-T-eyQlIc130_assertion description "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545608.RArYhzCQPUQgs3s_ZL8mBXU6rsHisUiF6-J3-T-eyQlIc130_provenance.